Table 3.
Demography of angiographic findings and outcome
| Variable | Study groups | P value | |||
|---|---|---|---|---|---|
| Control (N = 359) | DM alone (N = 178) | HT alone (N = 382) | DM and HT (N = 315) | ||
| Follow-up time (weeks) | 173.8 ± 106.8 | 155.4 ± 104.8 | 168.8 ± 99.7 | 160.9 ± 99.0 | 0.17 |
| Number of diseased vessels | <0.01* | ||||
| Single vessel disease | 206 (57.4%) | 74 (41.6%) | 186 (48.7%) | 124 (39.4%) | |
| Dual vessel disease | 93 (25.9%) | 55 (30.9%) | 107 (28.0%) | 100 (31.8%) | |
| Triple vessel disease | 60 (16.7%) | 49 (27.5%) | 89 (23.3%) | 91 (28.8%) | |
| Mean of treated vessels | 1.6 ± 0.8 | 1.9 ± 0.8 | 1.7 ± 0.8 | 1.9 ± 0.8 | <0.01* |
| Mean of treated lesions | 1.3 ± 0.7 | 1.4 ± 0.8 | 1.5 ± 0.8 | 1.6 ± 0.9 | <0.01* |
| Type of intervention | 0.81 | ||||
| Balloon angioplasty | 122 (30.0%) | 62 (15.2%) | 125 (30.7%) | 98 (24.1%) | |
| BMS deployment | 144 (28.7%) | 60 (11.8%) | 171 (33.7%) | 131 (25.8%) | |
| DES deployment | 116 (25.8%) | 68 (15.1%) | 137 (30.4%) | 129 (28.7%) | |
| Lesion location | 0.62 | ||||
| LAD | 249 (69.2%) | 138 (78.0%) | 288 (75.4%) | 183 (58.1%) | |
| Lcx | 163 (45.2%) | 96 (54.2%) | 183 (48.0%) | 191 (60.6%) | |
| RCA | 162 (45.0%) | 99 (55.9%) | 199 (52.0%) | 175 (55.6%) | |
| SYNTAX score | 10.8 ± 8.0 | 11.9 ± 7.9 | 10.1 ± 6.9 | 11.6 ± 8.5 | <0.01* |
| LVEF | 0.60 ± 0.13 | 0.55 ± 0.16 | 0.62 ± 0.13 | 0.59 ± 0.15 | 0.71 |
| MI | 0.09 | ||||
| yes | 15 (4.2%) | 14 (7.9%) | 12 (3.1%) | 17 (5.4%) | |
| no | 344 (95.8%) | 164 (92.1%) | 370 (96.9%) | 298 (94.6%) | |
| CV death | <0.01* | ||||
| yes | 20 (5.6%) | 24 (13.5%) | 13 (3.4%) | 17 (5.4%) | |
| no | 339 (94.4%) | 154 (86.5%) | 369 (96.6%) | 298 (94.6%) | |
| All-cause death | <0.01* | ||||
| yes | 35 (9.8%) | 36 (20.2%) | 21 (5.5%) | 22 (7.0%) | |
| No | 324 (90.3%) | 142 (79.8%) | 361 (94.5%) | 293 (93.0%) | |
| Re-PCI | 0.32 | ||||
| yes | 84 (23.4%) | 51 (28.7%) | 82 (21.5%) | 73 (23.2%) | |
| No | 275 (76.6%) | 127 (71.4%) | 300 (78.5%) | 242 (76.8%) | |
BMS bare metal stent, DES drug-eluting stent, LAD left anterior descending artery, Lcx left circumflex artery, RCA right coronary artery, SYNTAX score Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery score, LVEF left ventricular ejection fraction, MI myocardial infarction, Re-PCI repeated percutaneous coronary intervention. *: significant